Anthony S. Hale

Determination of the dose of agomelatine, a melatoninergic agonist and selective 5-HT2C antagonist, in the treatment of major depressive disorder: a placebo-controlled dose range study

Henri L o, Anthony S. Hale, H. D haenen · International Clinical Psychopharmacology · 2002 · 360 citations

Psychopharmacology, Pharmacotherapy, Social Sciences +16

Dopaminergic mechanism of antidepressant action in depressed patients

Paul Willner, Anthony S. Hale, Spilios V. Argyropoulos · Journal of Affective Disorders · 2005 · 167 citations

Psychiatry, Mood Symptom, Psychotropic Medication +8

Superior antidepressant efficacy results of agomelatine versus fluoxetine in severe MDD patients: a randomized, double-blind study

Anthony S. Hale, Ricardo Corral, Claudio Mencacci et al. · International Clinical Psychopharmacology · 2010 · 128 citations

Psychotropic Medication, Psychopharmacology, Agomelatine Versus Fluoxetine +19

Community care for patients with schizophrenia one year after hospital discharge.

David Melzer, Anthony S. Hale, Shasta Malik et al. · BMJ · 1991 · 118 citations · Full text

Clomipramine, Tryptophan and Lithium in Combination for Resistant Endogenous Depression: Seven Case Studies

Anthony S. Hale, Andrew Procter, P. K. Bridges · The British Journal of Psychiatry · 1987 · 61 citations

Resistant Depression, Psychotropic Medication, Psychopharmacology +17